486 Intrathecal (IT) trastuzumab in leptomeningeal and central nervous system (CNS) metastases from HER2+ breast cancer (BC): What if we could bypass the bloodbrain barrier (BBB)?

M.Oliveira; S.Braga; J.L.Passos-Coelho; J.Oliveira

首页> 外文期刊>European Journal of Cancer Supplements >486 Intrathecal (IT) trastuzumab in leptomeningeal and central nervous system (CNS) metastases from HER2+ breast cancer (BC): What if we could bypass the bloodbrain barrier (BBB)?

【24h】

486 Intrathecal (IT) trastuzumab in leptomeningeal and central nervous system (CNS) metastases from HER2+ breast cancer (BC): What if we could bypass the bloodbrain barrier (BBB)?

机译：486从HER2 +乳腺癌（BC）转移到鞘膜内（IT）曲妥珠单抗治疗的软脑膜和中枢神经系统（CNS）：如果我们可以绕过血脑屏障（BBB）怎么办？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2010年第3期|共2页
作者
M.Oliveira; S.Braga; J.L.Passos-Coelho; J.Oliveira;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-18 18:38:41

相似文献

外文文献
专利

1. 486 Intrathecal (IT) trastuzumab in leptomeningeal and central nervous system (CNS) metastases from HER2+ breast cancer (BC): What if we could bypass the bloodbrain barrier (BBB)? [J] . M.Oliveira, S.Braga, J.L.Passos-Coelho, European Journal of Cancer Supplements . 2010,第3期

机译：486从HER2 +乳腺癌（BC）转移到鞘膜内（IT）曲妥珠单抗治疗的软脑膜和中枢神经系统（CNS）：如果我们可以绕过血脑屏障（BBB）怎么办？
2. Progressive Central Nervous System Metastases in Responder Patients for Outside Central Nervous System Metastases on Trastuzumab-Based Therapy —Report of Two Cases of Refractory Breast Cancer [J] . Riki OKITA, Toshiaki SAEKI, Shigemitsu TAKASHIMA, Hiroshima journal of medical sciences . 2005,第1期

机译：基于曲妥珠单抗治疗的应答者患者中枢神经系统外转移进行性中枢神经系统转移-两例难治性乳腺癌报告
3. Progressive Central Nervous System Metastases in Responder Patients for Outside Central Nervous System Metastases on Trastuzumab-Based Therapy —Report of Two Cases of Refractory Breast Cancer [J] . Riki OKITA, Toshiaki SAEKI, Shigemitsu TAKASHIMA, Hiroshima journal of medical sciences . 2005,第1期

机译：基于曲妥珠单抗治疗的应答者患者中枢神经系统外转移进展性中枢神经系统转移-两例难治性乳腺癌报告
4. Bypassing the Blood-brain Barrier with Intranasal Delivery to Treat Central Nervous System Disorders [C] . Controlled Release Society annual meeting . 2004

机译：用鼻内递送绕过血脑屏障治疗中枢神经系统疾病
5. LPTO-08. INTRATHECAL TRASTUZUMAB PLUS/MINUS IT TOPOTECAN FOR PATIENTS WITH HER2+ BREAST CANCER AND LEPTOMENINGEAL METASTASIS [O] . Christopher R Trevino, Rashmi K Murthy, Akshara Singareeka Raghavendra, 2019

机译：LPTO-08。鞘内注射曲妥珠单抗加/减拓扑替康治疗患有HER2 +乳腺癌和全脑膜转移的患者
6. Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab [O] . Oliveira, Mafalda, Braga, Sofia, Passos-Coelho, José Luís, 2011

机译：鞘内使用曲妥珠单抗对乳腺癌HER2 +脑膜癌的完全缓解

486 Intrathecal (IT) trastuzumab in leptomeningeal and central nervous system (CNS) metastases from HER2+ breast cancer (BC): What if we could bypass the bloodbrain barrier (BBB)?

著录项

相似文献

相关主题

期刊订阅